Dr. Muhannad R. M. Salih Karamanjy, CEO of JENNA Group, has been a driving force in Iraq’s pharmaceutical and healthcare sector for over 25 years.

With a Ph.D. in Health Economy and Pharmacy Practice, along with his role as a part-time Professor at the Pharmacy Department, Al-Rasheed University College, Baghdad, Iraq, Dr. Muhannad brings a unique blend of academic expertise and practical experience to his leadership of JENNA Group. Under his visionary leadership, JENNA has grown from its initial focus into a leading partner for global pharmaceutical companies, excelling in marketing, distribution, and delivering high-quality healthcare products across Iraq.

Dr. Muhannad’s strategic direction has ensured that JENNA Group maintains a strong presence throughout the country with an emphasis on building long-term relationships with healthcare providers and international pharmaceutical brands. In addition to expanding JENNA’s core services, he has played a crucial role in fostering partnerships that bring cutting-edge healthcare solutions to the Iraqi market. His focus on innovation and adaptability has allowed JENNA Group to remain competitive while continually evolving to meet the healthcare needs of Iraq’s population. Through his unwavering dedication to excellence, Dr. Muhannad has set a benchmark for success in the region’s pharmaceutical landscape, ensuring that JENNA Group remains at the forefront of the industry.